ARCHIVES

FCRC Committee Limited To Review Of Basic Science

This article is from The Cancer Letter archive.

Vol. 02 No. 48 | November 26, 1976

Download PDF Visit The Full Archive

Related Articles

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

Emory Executive Objects to Report On Merit review

July 22, 1977

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

In Brief: Wittes DCT Acting Deputy Director; Spallone Leaves For Fox Chase; Ronald Evens Heads AUR

June 24, 1988

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008